Dear Jayne,

Do you know CenterWatch, the e-mail service and web site (see sample e-mail
letter below)? It admits that it is far from comprehensive, but with 3,000
trials listed it may still be the largest collection of clinical trials
extant. Here is what the web site has on MS:

Summary: Study for the prevention of multiple sclerosis

This study is designed to determine if treatment of first demyelinating
episode in patients at high risk for MS is beneficial in delaying
development of clinically definite MS or in decreasing disability.

Patients must be seen within 14 days of symptoms of first demyelinating
episode (optic neuritis, INO, paraparesis).

Patients who have been diagnosed with MS will be excluded from this study.

Contact:

[Then it has an on-line enrollment form]

Regards,

Michael Odza, Publisher,
Technology Access Report (for tech transfer professionals),
Intellectual Property Advice (for researchers)
and customized newsletters,
8 Digital Dr., Suite 250, Novato, CA 94949-5759
800/733-1516 (415/883-7600)
fax 415/883-6421

----------
> From: xxxxxx@aol.com
> To: xxxxxx@aol.com
> Subject: CW Weekly Patient Newsletter
> Date: Monday, March 10, 1997 8:39 AM
>
> CenterWatch Weekly Patient Newsletter
> For the week of March 3, 1997
> http://www.centerwatch.com
>
>
> NEWLY POSTED TRIALS
>
> MUSCULOSKELETAL
>
> Osteoporosis: Study for preventing new spinal fractures in women with
> postmenopausal osteoporosis.
> Locations:  This study is being conducted at 34 research centers across
the
> U.S. and Canada.  Please check the CW web site to find the location
nearest
> to you.
>
> NEUROLOGY
>
> Epilepsy: Study for patients with newly diagnosed seizures.
> Location: Boston, MA.
>
> OB/GYN
>
> Yeast Infections: Study comparing Clotrimazole 1-day regimen with
> Clotrimazole 7-day regimen for the treatment of vulvovaginal
> candidiasis/yeast vaginosis.
> Location: Champaign, IL.
>
> ONCOLOGY
>
> Colon Polyps: Study of patients with a history of colon polyps.
> Location: New York, NY.
>
> Liver Cancer: Study for patients with hepatocellular carcinoma.
> Locations: Lexington, KY; New Orleans, LA; Birmingham, AL; Manahsset, NY;
> Boston, MA.
>
>
> SITES ADDED TO PREVIOUSLY POSTED STUDIES
>
> Colon Malignancies: Study of an investigational agent added to standard
> colorectal cancer chemotherapy.
> New Location: Austin, TX.
>
> Diabetes: Study of an investigational agent to control blood sugar levels
in
> non-insulin dependent diabetics.
> New Location: Phoenix, AZ.
>
>
> NEWLY APPROVED DRUGS
>
> Alsara (imiquimod)
> Treatment for external genital and perianal warts
> Manufacturer: 3M Pharmaceuticals
>
>
> SPORANOX (itraconazole)
> Treatment for oral thrush
> Manufacturer: Janssen Pharmaceutica
>
>
> Metaprotereol Sulfate Inhalation Solution, 5%
> (Generic equivalent of Alupentr Inhalation Solution, 5%)
> Treatment for bronchial asthma and reversible bronchospasm
> Manufacturer: Morton Grove Pharmaceuticals, Inc.
>
>
> Tolmetin Sodium
> Treatment for arthritis
> Manufacturer: Teva Pharmaceutical Industries Ltd.
>
> -------------------------------------------------the
> end--------------------------------------------------------------
>